Biogen to Present at the Guggenheim 5th Annual Healthcare Conference
December 07 2017 - 4:01PM
Business Wire
Biogen Inc. (NASDAQ: BIIB) announced today that it will present
at the Guggenheim 5th Annual Healthcare Conference. The webcast
will be live on Wednesday, December 13, 2017 at 12:00 p.m.
ET. To access the live webcast, please visit Biogen’s
Investors section at www.biogen.com/investors. An archived version
of the webcast will be available following the presentation.
About BiogenThrough cutting-edge science and medicine,
Biogen discovers, develops and delivers innovative therapies
worldwide for people living with serious neurological and
neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in
biotechnology and today the Company has the leading portfolio of
medicines to treat multiple sclerosis, has introduced the first and
only approved treatment for spinal muscular atrophy, and is at the
forefront of neurology research for conditions including
Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral
sclerosis. Biogen also manufactures and commercializes biosimilars
of advanced biologics. For more information, please visit
www.biogen.com. Follow us on social media – Twitter, LinkedIn,
Facebook, YouTube.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171207005141/en/
BiogenKaren Jewell, 781-464-2442Investor Relations
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Apr 2023 to Apr 2024